HYGEIA Hospital
ΜΗΤΕΡΑ
Παίδων ΜΗΤΕΡΑ
ΛΗΤΩ Μαιευτικό, Γυναικολογικό & Χειρουργικό Κέντρο
HYGEIA Hospital Tirana
Υγείαnet
Y-Logimed Α.Ε.
AlfaLab | Kέντρο Μοριακής Βιολογίας & Κυτταρογενετικής
Beatific® | Super-effective Anti-aging Skincare for Face - Eyes - Body

Hepatobiliary Surgery


The Department offers a comprehensive range of services that focus on prevention, diagnosis and treatment of any benign or malignant condition of the liver and pancreas, by implementing individualized and contemporary techniques for the management of both primary and secondary liver cancer.

It boasts a qualified team of healthcare professionals, consisting of a liver surgeon, a pancreatic & hepatobiliary surgeon, an interventional radiologist, medical oncologists, interventional gastroenterologists and fully trained OR staff. Furthermore, the HYGEIA Intensive Care Unit has extensive experience in handling similar conditions.

To this day, more than 110 hepatobiliary surgical procedures (over 60 major hepatectomies) have been performed at HYGEIA. The average hospitalization for these procedures is 3.5-5 days (a period that corresponds to the lowest in Europe).

The quality indexes for the Department, as defined by the completion of resections, the rate of postoperative complications, the hospitalization days and patient survival, are on par with some of the leading oncology centers in North America.


Specifically, along with other subspecialties (interventional radiology, radiotherapy, oncology and hepatology), it manages the following conditions:

  • Primary malignant neoplasms of the liver, such as hepatoma and intrahepatic cholangiocarcinoma, even on cirrhotic areas.
  • Primary malignant neoplasms of the biliary tract (Klatskin tumor/cholangiocarcinoma, intrapancreatic cholangiocarcinoma).
  • Metastatic liver disease (hepatic metastases) from colon cancer, stomach cancer, breast cancer, neuroendocrine tumors, etc.
  • Benign liver tumors, such as hepatocellular adenoma, hemangioma, focal nodular hyperplasia, etc.
  • Benign conditions of the biliary tract, such as benign stenoses, bile duct injuries, etc.

Apart from conventional hepatectomy, other minimally invasive thermal tumor ablation techniques are also used to treat liver metastases. These include radiofrequency ablation (RFA) and microwave ablation (MWA), which cause necrosis of the metastases, keeping the adjoining liver intact. They may be performed without surgery (percutaneously), laparoscopically, but also during surgery, in combination with the removal of other tumors.

The Department also implements all the latest laparoscopic techniques, such as laparoscopic hepatectomy and simultaneous colectomy and hepatectomy, which treats colon cancer and liver metastases at the same time. Some of the benefits of these methods include small incisions, minimum postoperative pain, fast recovery and lower complication rates, especially in simultaneous colectomy and hepatectomy, which is not the case when the procedures are performed at different times.

In addition, the Department activities include treatment for benign and malignant tumors of the pancreas, duodenum and retroperitoneal space.


The research activities of the Hepatobiliary Surgery Department focus on clinical studies on the following topics:

  • Analysis of survival rates following hepatectomy in patients with extensive metastatic liver disease.
  • Analysis of the effectiveness in the application of RFA and MWA in patients with primary and metastatic liver disease.
  • Use of transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma.
  • Application of fast-track protocol in patients that have undergone hepatectomy.
  • Use of neoadjuvant chemotherapy in patients with pancreatic adenocarcinoma.

4th floor
Office 42

Telephone
+30 210 686 7000
+30 210 683 8241

Medical Team